Latest Chemie Grünenthal of Stolberg-am-Rhein Stories
MILAN, September 22, 2010 /PRNewswire/ -- After having handled the worldwide launch of tapentadol, the innovative drug for the severe acute pain, Alberto Grua has been appointed Grunenthal Europe and Australia Executive Vice President.
RARITAN, N.J., Aug. 30 /PRNewswire/ -- Phase 3 safety and efficacy data comparing tapentadol extended release (ER) tablets, an investigational pain medication, to placebo in patients with moderate to severe chronic osteoarthritis knee pain have been published by Clinical Drug Investigation.
RARITAN, N.J., May 3 /PRNewswire/ -- Data on tapentadol for the relief of acute and chronic pain, as well as patient and prescriber perceptions of oxycodone immediate-release treatments, will be presented at the 29th Annual Scientific Meeting of the American Pain Society (APS) May 6-8, 2010. Four of the 12 poster presentations will review analyses of tapentadol data, including a post-hoc analysis of a Phase 3 tolerability study on NUCYNTAÂ® (tapentadol) tablets for acute pain in elderly...
Thalidomide victims once snubbed by the German government are being offered compensation for birth defects caused by the drug, officials say. The German family ministry has announced it will temporarily waive a 26-year-old ban on considering thalidomide relief claims from foreign countries until the end of 2010, thus enabling victims from around the world to collect damages on the drug formerly made by the German company Grunenthal, The Sunday Times of London reported. Germany since 1983 has...
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.